ARTICLE | Company News
Amgen, Selexis deal
February 25, 2013 8:00 AM UTC
The companies expanded a 2004 R&D license to grant Amgen non-exclusive rights to use Selexis' SURE CHO-M cell line development technology and SUREtech Vectors. The parties declined to disclose details...